ZADA Pharmaceuticals

What ZADA Pharmaceuticals does

ZADA Pharmaceuticals d.o.o. is a privately held pharmaceutical manufacturer headquartered in Lukavac, Bosnia and Herzegovina, founded in 2007 with 51-100 employees. The company operates a GMP-certified manufacturing facility compliant with European GMP guidelines and certified by ALMBiH (Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina) to produce solid dosage forms — tablets, film-coated tablets, and capsules. Its portfolio comprises over 150 products spanning 9 ATC therapeutic groups, organized into three lines: prescription (Rx) medicines, over-the-counter (OTC) medications, and the MAXIMA line of dietary supplements with differentiated formulations such as Kurkumin FORTE (turmeric extract with added piperine for bioavailability), Thinny, PROSTA Balance, and immune-support products. Quality control is performed in six analytical laboratories equipped with HPLC, FTIR, and NIR instrumentation, with quality management structured around EU GMP and EN ISO 9001.

The company generates revenue primarily through product sales distributed via licensed pharmacy networks and healthcare institutions across Bosnia and Herzegovina, supplemented by contract manufacturing services offered to third parties using its GMP-certified production capacity. ZADA holds an ongoing educational and scientific partnership with the Faculty of Pharmacy in Tuzla (since 2009), in which its staff deliver practical training and serve as faculty assistants. Marketing activities include a multilingual website (Bosnian, English, Russian), social media, healthcare-professional event participation, and content marketing through a company magazine. The firm is independently owned as a d.o.o. (private limited liability company), with no disclosed parent company, institutional investors, or venture funding, and operates solely within the domestic Bosnian market.

Name

ZADA Pharmaceuticals

Legal name

ZADA Pharmaceuticals d.o.o.

Website

https://zada.ba

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• Generic pharmaceuticals
• Prescription drug manufacturing
• OTC medications
• Dietary supplements
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Lukavac

HQ country

Bosnia & Herzegovina

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling prescription drugs (Rx), over-the-counter (OTC) medications, and dietary supplements (MAXIMA line) through pharmacy distribution networks.
2. Contract Manufacturing: The company offers contract manufacturing services for pharmaceutical products using their GMP-certified production capabilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ZADA Pharmaceuticals manufactures and sells prescription (Rx) drugs, over-the-counter (OTC) medications, and MAXIMA-branded dietary supplements from a GMP-certified facility in Lukavac, Bosnia and Herzegovina. The company produces over 150 drugs across 9 ATC therapeutic groups in solid dosage forms (tablets, film-coated tablets, capsules), certified by ALMBiH and operating under EU GMP and EN ISO 9001 quality systems. It also offers contract manufacturing services for third-party pharmaceutical products using its GMP-certified production capabilities.

Product overview

ZADA Pharmaceuticals is a pharmaceutical company in Bosnia and Herzegovina producing solid dosage forms (tablets, film-coated tablets, and capsules) certified by ALMBiH. The product portfolio includes three main categories: (1) Prescription drugs - over 150 medicines across 9 ATC therapeutic groups for physician-prescribed treatment; (2) OTC medicines - over-the-counter medications for pain, inflammation, cramps, circulation, and heartburn; (3) MAXIMA dietary supplements - a line of unique formulations including Kurkumin FORTE (turmeric extract with enhanced bioavailability), Thinny (glucomannan-based weight management), PROSTA Balance (prostate health), and various vitamin/mineral supplements (ZinC-D, C-ZAD, Kalcijum Plus, Magnezijum Plus), plus immune support products (BETA-G Imuno, BETA-G Kids). All products are manufactured according to European GMP guidelines.

Differentiator

Problem solved

Functional benefit

Brands

• MAXIMA: A line of dietary supplements with various formulations, unique in the market.

Products and services

• Prescription Drugs (Rx) Over 150 prescription-only medicines spanning 9 ATC therapeutic groups, covering multiple therapeutic areas for physician-prescribed treatment. Manufactured at the company's ALMBiH-certified GMP facility in Lukavac. Intended for healthcare institutions, hospitals, clinics, and licensed pharmacies in Bosnia and Herzegovina.
• OTC Medicines Over-the-counter medications used for relief of various pain types, inflammation, cramps, blood circulation support, and heartburn symptom relief. Manufactured at the ALMBiH-certified GMP facility in Lukavac and distributed through licensed pharmacies.
• MAXIMA Dietary Supplements Branded dietary supplement line marketed under the MAXIMA sub-brand, featuring unique formulations including Kurkumin FORTE, Thinny, PROSTA Balance, BETA-G Imuno/Kids, Relaxan/Relaxan Dreams, Magnezijum Plus, Kalcijum Plus, C-ZAD, and ZinC-D. Sold through licensed pharmacies across Bosnia and Herzegovina.
• Contract Manufacturing Services Contract manufacturing services for solid dosage forms (tablets, film-coated tablets, and capsules) using ZADA's GMP-compliant production facility. Available to third-party pharmaceutical clients seeking certified regional manufacturing capacity.
• Kurkumin FORTE Dietary supplement containing 500 mg turmeric extract (Curcuma longa) standardized to 95% curcuminoids and 5 mg black pepper extract standardized to 98% piperine, supporting liver protection, joint health, antioxidant activity, and anti-inflammatory benefits. Reformulated in 2020 to improve bioavailability.
• Thinny Weight management dietary supplement containing 500 mg glucomannan (Amorphophallus konjac root extract) and 0.025 mg chromium (as chromium picolinate), designed to promote satiety, support weight loss, and help maintain normal cholesterol and glucose levels.
• ZinC-D Dietary supplement combining zinc and vitamin D, designed to support immune function. Sold as part of the MAXIMA dietary supplement line through licensed pharmacies.
• Tiacid Dietary supplement product in the ZADA Pharmaceuticals portfolio, distributed through licensed pharmacies in Bosnia and Herzegovina.
• Relaxan Dietary supplement within the ZADA MAXIMA product line, distributed through licensed pharmacies.
• Relaxan Dreams Dietary supplement within the MAXIMA line providing sleep and relaxation support, distributed through licensed pharmacies.
• Magnezijum Plus Magnesium dietary supplement within the MAXIMA product line, distributed through licensed pharmacies in Bosnia and Herzegovina.
• Kalcijum Plus Calcium dietary supplement within the MAXIMA product line, distributed through licensed pharmacies in Bosnia and Herzegovina.
• C-ZAD Vitamin C dietary supplement within the ZADA product line, distributed through licensed pharmacies in Bosnia and Herzegovina.
• BETA-G Imuno Immune support supplement containing beta-glucane (immunostimulator), vitamin C, zinc, and coenzyme Q10. Marketed to enhance immune response up to sevenfold.
• BETA-G Kids Children's immune support dietary supplement in chewable tablet form (orange flavor) containing beta-glucane and vitamin C, formulated for children aged 3–12 years.
• PROSTA Balance Dietary supplement within the MAXIMA line designed to support prostate health.

Quantifiable outcome

• 150+ drugs produced across 9 ATC therapeutic groups
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Faculty of Pharmacy in TuzlacoreStrategic or Co-development Partner · 1 January 2009ZADA Pharmaceuticals has been a scientific and educational base for the Faculty of Pharmacy in Tuzla since 2009. Students receive practical training in subjects including Drug Analysis and Control I and II and Pharmaceutical Technology at ZADA facilities under supervision of company staff. ZADA employees serve as assistants or senior assistants at the faculty.

Scale indicators3 records

Direct peers

• Krka: Slovenian generic pharmaceutical manufacturer with a broad solid-dosage portfolio across multiple therapeutic areas and active contract manufacturing/CDMO operations. Highly comparable on product format, ATC breadth, and CEE market focus.
• Bosnalijek: Bosnia and Herzegovina's other large domestic pharmaceutical manufacturer, producing Rx, OTC, and supplement products with a comparable GMP-certified portfolio. Most directly comparable peer given shared domestic market, regulatory regime, and customer base.
• Hemofarm: Serbian pharmaceutical manufacturer (part of STADA group) producing generics, OTC, and supplements in solid dosage forms. Comparable regional player with similar manufacturing footprint, ATC breadth, and Balkan distribution model.
• Alkaloid: North Macedonian pharmaceutical company manufacturing Rx generics, OTC products, and supplements with EU GMP certification. Similar in scale, geographic remit, and dosage-form focus to ZADA.

Broad incumbents

• Viatris: Global generics and biosimilars company formed from Mylan and Upjohn, with a sizable off-patent solid-dose franchise in CEE. Acts as a pricing benchmark and global generics competitor in regional tenders.
• Polpharma: One of the largest Central European generic pharmaceutical manufacturers, with broad Rx and OTC portfolios across solid dosage forms. Comparable on manufacturing and generic-positioning even though its primary market is Poland and the Baltics.
• Sandoz: Global generics leader (Novartis spin-off) with an extensive off-patent solid-dose portfolio and significant CEE/Balkan presence. Sets the competitive ceiling on pricing and tender participation in BiH's public procurement market.
• STADA Arzneimittel: European-focused generics and consumer healthcare company whose portfolio now includes Hemofarm. Provides a useful comparable for the regional generics plus consumer health model ZADA is operating.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer, with broad solid-dosage offerings and a meaningful presence across CEE. Competes indirectly via distribution and tender pricing across the Balkan region.
• Zentiva: Pan-European generics manufacturer with a strong Central and Eastern European footprint including the Balkans. Competes with ZADA in tenders and pharmacy distribution but operates at far greater scale across many dosage forms and geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCz8Qai7pKce4L6zL2KVMy_g
• Facebookfacebook.com/ZADA-Pharmaceuticals-352989081540011
• LinkedInlinkedin.com/company/zada-pharmaceuticals

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZADA Pharmaceuticals